Share Facebook Twitter Email December 22, 2022 A no for low. While molecular profiling may stratify prognosis across different types of high-grade endometrial carcinoma, it does not appear to be associated with outcomes for low-grade disease in this retrospective look. Citation(s) Vrede, JAMA Netw Open 2022